Atlasclear stock soars after closing $3M financing deal

Investing.com -- CDT Equity Inc. (NASDAQ:CDT) stock surged 36% Wednesday after the company announced the strategic acquisition of 8.65 Bitcoin (BTC) for $1 million, representing an average price of $115,285 per BTC.

The purchase, which includes fees and expenses, marks a significant step in CDT’s treasury reserve strategy aimed at strengthening its financial position and balance sheet resilience. The company’s shares jumped as investors responded to this move into digital assets.

James Bligh, Chief Financial Officer of CDT, stated, "We are pleased to execute the definitive step in our cryptocurrency-based treasury reserve strategy, which is designed to diversify the Company’s balance sheet and reinforce its innovation-led business model."

The company indicated that the Bitcoin acquisition aligns with accelerating institutional adoption of digital assets within an evolving regulatory environment that is increasingly enabling broader acceptance of cryptocurrencies.

CDT’s management noted they continue to evaluate their asset allocation to optimize the treasury portfolio and shareholder returns. The Bitcoin purchase represents the company’s first reported entry into cryptocurrency holdings as part of its treasury strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com – Poland stocks were lower after the close on Wednesday, as losses in the Basic Materials, Chemicals and Energy sectors led shares lower.

At the close in Warsaw, the WIG30 lost 0.23%.

The best performers of the session on the WIG30 were Text SA (WA:TXTP), which rose 2.66% or 1.35 points to trade at 52.05 at the close. Meanwhile, Kruk SA (WA:KRU) added 2.22% or 10.40 points to end at 478.40 and Cyfrowy Polsat SA (WA:CPS) was up 1.84% or 0.25 points to 13.85 in late trade.

The worst performers of the session were KGHM Polska Miedz SA (WA:KGH), which fell 2.94% or 4.10 points to trade at 135.25 at the close. X Trade Brokers Dom Maklerski SA (WA:XTB) declined 2.25% or 1.66 points to end at 72.20 and Tauron Polska Energia SA (WA:TPE) was down 1.63% or 0.15 points to 8.81.

Falling stocks outnumbered advancing ones on the Warsaw Stock Exchange by 315 to 233 and 87 ended unchanged.

Shares in Kruk SA (WA:KRU) rose to 52-week highs; rising 2.22% or 10.40 to 478.40.

Crude oil for October delivery was down 0.56% or 0.36 to $64.16 a barrel. Elsewhere in commodities trading, Brent oil for delivery in November fell 0.55% or 0.38 to hit $68.09 a barrel, while the December Gold Futures contract fell 0.14% or 5.18 to trade at $3,719.92 a troy ounce.

EUR/PLN was up 0.15% to 4.25, while USD/PLN rose 0.31% to 3.59.

The US Dollar Index Futures was up 0.13% at 96.38.

Investing.com -- Visionary Education Technology Holdings Group Inc (NASDAQ:GV) stock surged 76.4% Wednesday after the company announced a strategic partnership with Jiangsu Yike Regenerative Medicine, a leading Chinese regenerative medical research institute.

The technology-driven multinational enterprise will collaborate with Yike on research, development, and commercialization in cellular rejuvenation and aesthetic treatment. This partnership marks GV’s strategic entry into the Consumption Healthcare sector, specifically targeting the Medical Aesthetics industry.

Under the agreement, Yike will lead and fund the research and development efforts, while GV may later acquire or license the intellectual property rights through cash or share-based transactions. The partnership will focus on cell activation and telomerase homeostasis, smart delivery systems with personalized solutions, and stem cell applications.

The collaboration will leverage Yike’s proprietary technologies, including its Cell-Activating Complex, Nano-Delivery ultra-permeable liposomal technology, and AI-based Aging Assessment Model. GV will work closely with Dr. Zhenyu Ju, Yike’s Chief Scientist and Dean of the Institute of Aging and Regenerative Medicine at Jinan University.

Dr. Ju, a recipient of China’s National Science Fund for Distinguished Young Scholars, stated: "We are very pleased to collaborate with GV, a company with strong international marking experience and global vision. GV’s global resources and commercialization experience are highly complementary to Yike’s research into aging interventions. This partnership will accelerate the translation of fundamental research into clinical applications, delivering safer and more effective anti-aging solutions to consumers in China and worldwide."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.